Quangang J. Chen

Wuxi, 214023, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Active surveillance of adverse event within 7 days of single versus simultaneous administration of diphtheria, tetanus, and acellular pertussis combined vaccine in children aged 2-month and 6-year-old

Active surveillance of adverse event within 7 days of single versus simultaneous administration of diphtheria, tetanus, and acellular pertussis combined vaccine in children aged 2-month and 6-year-old

Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]

Published: June 22, 2026

Single- and dual-target CAR-T cells targeting HBsAg and GPC3 to balance safety and antitumor efficacy in HBV-positive hepatocellular carcinoma.

Single- and dual-target CAR-T cells targeting HBsAg and GPC3 to balance safety and antitumor efficacy in HBV-positive hepatocellular carcinoma.

Journal: iScience

Published: January 30, 2026

Single-cell RNA sequencing analysis reveals a novel porcine alveolar macrophage subtype with high SLAMF7 expression promoting PRRSV infection.

Single-cell RNA sequencing analysis reveals a novel porcine alveolar macrophage subtype with high SLAMF7 expression promoting PRRSV infection.

Journal: Virulence

Published: September 13, 2025

Pan-cancer analysis shows that TRIP13 as a potential prognostic and immunotherapeutic biomarker for multiple cancer types including LIHC and LUAD.

Pan-cancer analysis shows that TRIP13 as a potential prognostic and immunotherapeutic biomarker for multiple cancer types including LIHC and LUAD.

Journal: Medicine

Published: May 29, 2025

Pan-Cancer Analysis Identifies DIP2B as a Potential Biomarker That Inhibits Kidney Renal Clear Cell Carcinoma Progression.

Pan-Cancer Analysis Identifies DIP2B as a Potential Biomarker That Inhibits Kidney Renal Clear Cell Carcinoma Progression.

Journal: IUBMB life

Published: April 14, 2025

VEGFB167 drives tumor progression by modulating the immune microenvironment.

VEGFB167 drives tumor progression by modulating the immune microenvironment.

Journal: International immunopharmacology

Published: April 03, 2025

The prognostic value of bioinformatics analysis of ECM receptor signaling pathways and LAMB1 identification as a promising prognostic biomarker of lung adenocarcinoma.

The prognostic value of bioinformatics analysis of ECM receptor signaling pathways and LAMB1 identification as a promising prognostic biomarker of lung adenocarcinoma.

Journal: Medicine

Published: September 23, 2024

PRRSV infection facilitates the shedding of soluble CD163 to induce inflammatory responses.

PRRSV infection facilitates the shedding of soluble CD163 to induce inflammatory responses.

Journal: Veterinary microbiology

Published: May 13, 2024

Comprehensive characterization of MUC16 mutations in lung adenocarcinoma for immunotherapies and prognosis: An observational study.

Comprehensive characterization of MUC16 mutations in lung adenocarcinoma for immunotherapies and prognosis: An observational study.

Journal: Medicine

Published: November 07, 2023

Conditional Knockout of IL-1R1 in Endothelial Cells Attenuates Seizures and Neurodegeneration via Inhibiting Neuroinflammation Mediated by Nrf2/HO-1/NLRP3 Signaling in Status Epilepticus Model.

Conditional Knockout of IL-1R1 in Endothelial Cells Attenuates Seizures and Neurodegeneration via Inhibiting Neuroinflammation Mediated by Nrf2/HO-1/NLRP3 Signaling in Status Epilepticus Model.

Journal: Molecular neurobiology

Published: June 06, 2023

Comprehensive analysis identifies DNA damage repair-related gene HCLS1 associated with good prognosis in lung adenocarcinoma.

Comprehensive analysis identifies DNA damage repair-related gene HCLS1 associated with good prognosis in lung adenocarcinoma.

Journal: Translational cancer research

Published: May 29, 2023

In silico analysis reveals PRR11 as a prognostic and oncogenic marker in lung adenocarcinoma.

In silico analysis reveals PRR11 as a prognostic and oncogenic marker in lung adenocarcinoma.

Journal: Medicine

Published: May 26, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026